Telaprevir prevents the growth of breast cancer cell lines by interfering with the IGF‐1R pathway leading to FOXA1 down‐regulation, ERα inhibition, and induction of apoptotic cell death. The gene discussed is FOXA1; the disease is breast carcinoma.